UNITED THERAPEUTICS Corp SEC filings UTHR
UNITED THERAPEUTICS Corp has 1,005 filings in SEC EDGAR's recent list, going back to Apr 7, 2023. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Oct 22, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Other events
|
Oct 14, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 23, 2026 | Jul 22, 2026 |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 POS | Filing | Jul 13, 2026 | — |
| S-8 | Employee stock plan registration | Jul 13, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 29, 2026 | Jun 26, 2026 |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| 10-K | Annual report | Feb 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jan 22, 2026 | Jan 21, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2025 | Oct 29, 2025 |
| 10-Q | Quarterly report | Oct 29, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 1, 2025 | Aug 1, 2025 |
| S-8 | Employee stock plan registration | Jul 30, 2025 | — |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| 10-Q | Quarterly report | Jul 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 27, 2025 | Jun 26, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 8-K |
Current report
Results of operations
|
Apr 30, 2025 | Apr 30, 2025 |
| 10-Q | Quarterly report | Apr 30, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Apr 28, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 10-K | Annual report | Feb 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2024 | Oct 30, 2024 |
| 10-Q | Quarterly report | Oct 30, 2024 | Sep 30, 2024 |
| S-8 | Employee stock plan registration | Jul 31, 2024 | — |
| 8-K |
Current report
Results of operations
|
Jul 31, 2024 | Jul 31, 2024 |
| 10-Q | Quarterly report | Jul 31, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Jun 27, 2024 | Jun 26, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| 8-K |
Current report
Results of operations
|
May 1, 2024 | May 1, 2024 |
| 10-Q | Quarterly report | May 1, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Other events
|
Feb 27, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 21, 2024 | Feb 21, 2024 |
| 10-K | Annual report | Feb 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| SC TO-T/A | Filing | Dec 13, 2023 | — |
| CORRESP | Letter to the SEC | Dec 13, 2023 | — |
| SC TO-T/A | Filing | Dec 12, 2023 | — |
| SC TO-T/A | Filing | Dec 4, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 29, 2023 | Nov 27, 2023 |
| SC TO-T | Filing | Nov 13, 2023 | — |
| SC TO-C | Filing | Nov 1, 2023 | — |
| 8-K |
Current report
Results of operations
|
Nov 1, 2023 | Nov 1, 2023 |
| 10-Q | Quarterly report | Nov 1, 2023 | Sep 30, 2023 |
| SC TO-C | Filing | Oct 30, 2023 | — |
| SC TO-C | Filing | Oct 30, 2023 | — |
| S-8 | Employee stock plan registration | Aug 2, 2023 | — |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Other events
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jul 14, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 28, 2023 | Jun 26, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| 10-Q | Quarterly report | May 3, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 21, 2023 | Apr 20, 2023 |
Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- UTHR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Silver Spring, MD
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1082554
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.